Statin dose-dependently induces ß cell damage and insulin resistance in the smooth muscle cells [31], reduces glucose transporter 4 (GLUT4) expression which is involved in glucose uptake in the peripheral cells [31–33], and decreases insulin signaling [34, 35]. The gene discussed is SLC2A4; the disease is Insulin resistance.